Astraea

Active

Agents that accelerate clinical trials.

Spring 2026Founded 20262 peopleSan Francisco, CA, USA

tryastraea.com ↗LinkedIn ↗

Generate ideas →

AI insightcan contain mistakes

Clinical Trial Data AutomationSaaSPharma sponsors and clinical research organizationsMedium competition

Moat

CDISC and FDA-compliant automation creates defensibility; audit trail and review workflows build switching costs.

Key risk

Pharma building internal AI; regulatory scrutiny on AI-generated data could slow adoption.

Why now

Clinical trial timelines under pressure; AI automation of SDTM and ADaM reduces months of manual work.

Competitors

Veeda, Medidata, In-house pharma data teams

About

Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.

Founders · 2

Sanmay SaradaFounder

Stanford🎓 Baylor College

prev Data Engineer @ Baylor College of Medicine | 4 Publications in Fetal Medicine | CS and Bio at Stanford

LinkedIn ↗

Joshua WangFounder

Stanford

Previous undergraduate at Stanford studying CS and Math. Top 250 united states (USAMO) Qualifier, USACO Platinum, first intern at Salient (W23) developing enterprise systems.

LinkedIn ↗

B2BArtificial IntelligenceSaaSHealth Tech

Related startups

Enjamb LabsSpring 2026

Full stack AI Agents accelerating Biopharma R&D

Biopharma Clinical Trial AutomationActive

PhasesSummer 2025

Automated clinical trial oversight and execution

Active

3 more related startups + AI insights

Free account · no credit card.

Also in Spring 2026

HeyClicky Huscarl Thomas Cohesion Maquoketa Research Intelligence Factory